Barry Schmetter

Structured Treatment Interruption in Patients with Multidrug-Resistant Human Immunodeficiency Virus

Jody Lawrence, Douglas L. Mayers, Katherine Huppler Hullsiek et al. · New England Journal of Medicine · 2003 · 265 citations · Full text

A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial

Rodger D. MacArthur, Richard M. Novak, Grace Peng et al. · The Lancet · 2006 · 138 citations

Protease Inhibitors, Long-term Randomised Trial, Treatment And Prevention +9

Prevalence of Antiretroviral Drug Resistance Mutations in Chronically HIV-Infected, Treatment-Naive Patients: Implications for Routine Resistance Screening before Initiation of Antiretroviral Therapy

Richard M. Novak, L. Chen, Rodger D. MacArthur et al. · Clinical Infectious Diseases · 2005 · 129 citations · Full text

A Multicenter Trial Evaluation of the Fibrin/Fibrinogen Degradation Products Test for Detection and Monitoring of Bladder Cancer

Barry Schmetter, K. K. Habicht, Donald L. Lamm et al. · The Journal of Urology · 1997 · 127 citations

Sustained Benefit From a Long-Term Antiretroviral Adherence Intervention

Sharon Mannheimer, Edward V. Morse, John P. Matts et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2006 · 111 citations